Sana Biotechnology is a biotechnology company, focusing on utilizing engineered cells as medicines. Co. is developing ex vivo and in vivo cell engineering platforms for treatment across therapeutic areas including oncology, diabetes, central nervous system disorders, cardiovascular diseases, and genetic disorders, among others. Co.'s ex vivo cell engineering pipeline includes its allogeneic T cell program that target CD19 to treat patients with refractory lymphoma. Co.'s in vivo cell engineering pipeline includes its CAR T cell fusosome product candidates (SG242, SG295) target CD19+ cancer cells, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia. We show 14 historical shares outstanding datapoints in our SANA shares outstanding history coverage, used to compute SANA market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SANA market cap history over the course of time is important for investors
interested in comparing SANA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SANA versus a peer is one thing; comparing
SANA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SANA can fluctuate over the course of history.
With this page we aim to empower investors researching SANA by allowing them to research the SANA market cap history. |
Free SANA Email Alerts:
Video: The Importance of Market Cap
